Type 2 diabetes mellitus
Conditions
Interventions
Type 2 diabetes mellitus:NA
Sponsors
Third Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Study centers: Endocrinology department in tier 2 and over tier 2 hospital Head of the department willing to improve the diabetes care management in the department through educational training and coaching Adopter of treatment pathway for diabetes management At least 60%outpatient endocrinologists will attend the iterative education program Patients: Outpatient with type 2 diabetes mellitus (T2DM) Man or woman aged =18 years Using basal insulin either in monotherapy or in combination with oral antidiabetic drugs (OADs) for =3 months Followed up in the study site for =3months before enrollment Hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) tests performed at the site within 1 month before patient enrollment Signed informed consent obtained prior to any study procedure
Exclusion criteria
Exclusion criteria: Patients: Diabetes other than T2DM (e.g. type 1 diabetes mellitus, diabetes secondary to pancreatic disorders, drug or chemical agent intake)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of hospitals successful in basal insulin quality improvement;hospital achieving the individualized quality improvement goal preset by Study Committees; | — |
Secondary
| Measure | Time frame |
|---|---|
| The percentage of patients achieving the glucose goal (HbA1c <7%) at baseline and the end of Month 6;The average HbA1c at baseline and the end of Month 6;The average FPG at baseline and the end of Month 6;The percentage of patients achieving the FPG goal (FPG <6.1 mmol/L) at baseline and the end of Month 6;The rate of hypoglycemia events at baseline and the end of Month 6;The rate of severe hypoglycemia events at baseline and the end of Month 6;The patients quality of life assessed by EuroQoL-5Dimensions (EQ-5D) at baseline and the end of Month 6;The investigators confidence in basal insulin assessment by questionnaire at baseline and the end of Month 6;The investigators daily practice in basal insulin assessment by questionnaire at baseline and the end of Month; | — |
Countries
China
Contacts
Public ContactZHANG Tong
Outcome results
None listed